1. Home
  2. MDCX vs CPIX Comparison

MDCX vs CPIX Comparison

Compare MDCX & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDCX
  • CPIX
  • Stock Information
  • Founded
  • MDCX 2008
  • CPIX 1999
  • Country
  • MDCX Canada
  • CPIX United States
  • Employees
  • MDCX N/A
  • CPIX N/A
  • Industry
  • MDCX
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDCX
  • CPIX Health Care
  • Exchange
  • MDCX Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • MDCX 33.8M
  • CPIX 35.4M
  • IPO Year
  • MDCX N/A
  • CPIX 2009
  • Fundamental
  • Price
  • MDCX $2.83
  • CPIX $4.64
  • Analyst Decision
  • MDCX Strong Buy
  • CPIX
  • Analyst Count
  • MDCX 1
  • CPIX 0
  • Target Price
  • MDCX $10.00
  • CPIX N/A
  • AVG Volume (30 Days)
  • MDCX 9.2K
  • CPIX 4.5M
  • Earning Date
  • MDCX 01-01-0001
  • CPIX 03-04-2025
  • Dividend Yield
  • MDCX N/A
  • CPIX N/A
  • EPS Growth
  • MDCX N/A
  • CPIX N/A
  • EPS
  • MDCX N/A
  • CPIX N/A
  • Revenue
  • MDCX N/A
  • CPIX $36,785,442.00
  • Revenue This Year
  • MDCX N/A
  • CPIX N/A
  • Revenue Next Year
  • MDCX N/A
  • CPIX N/A
  • P/E Ratio
  • MDCX N/A
  • CPIX N/A
  • Revenue Growth
  • MDCX N/A
  • CPIX N/A
  • 52 Week Low
  • MDCX $1.80
  • CPIX $1.04
  • 52 Week High
  • MDCX $3.23
  • CPIX $6.43
  • Technical
  • Relative Strength Index (RSI)
  • MDCX N/A
  • CPIX 83.81
  • Support Level
  • MDCX N/A
  • CPIX $2.08
  • Resistance Level
  • MDCX N/A
  • CPIX $6.43
  • Average True Range (ATR)
  • MDCX 0.00
  • CPIX 0.53
  • MACD
  • MDCX 0.00
  • CPIX 0.27
  • Stochastic Oscillator
  • MDCX 0.00
  • CPIX 74.94

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: